Aliskiren Tablet, Film Coated
Product Images NDC 49884-425

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aliskiren (NDC 49884-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aliskiren-chem-stru (Aliskiren Tablets 1)

Chemical structure of Aliskiren, showing the detailed molecular arrangement including functional groups such as hydroxyl, amine, and carboxyl groups.*

FDA Label Image

Aliskiren (Aliskiren Tablets 2)

A scatter plot illustrating the impact of co-administered drugs on the pharmacokinetics (PK) of aliskiren. It shows fold change and 90% confidence intervals for Cmax and AUC values of various interacting drugs, grouped under CYP3A4/P-gp inhibitors, antihypertensives, and others. The x-axis represents change relative to aliskiren alone, while the y-axis lists individual drugs with dosing details. Recommendations such as 'avoid concomitant use' and 'no dose adjustment' are noted.*

FDA Label Image

Aliskiren (Aliskiren Tablets 3)

A pharmacokinetic impact chart illustrating how aliskiren affects co-administered drugs. The chart lists various interacting drugs, including antihypertensives and others, along with corresponding pharmacokinetic parameters Cmax and AUC. It shows fold changes and 90% confidence intervals relative to the interacting drug alone, with recommendations indicating no dose adjustment is needed.*

FDA Label Image

Cntr-lbl-150mg (Aliskiren Tablets 4)

Aliskiren Tablets 150 mg film-coated oral tablets label from Par Pharmaceutical. The label states the active ingredient amount equivalent to 150 mg Aliskiren, package quantity of 30 tablets, and storage instructions at controlled room temperature. It includes manufacturer and distributor information, a barcode, and warnings to keep medication away from children.*

FDA Label Image

Cntr-lbl-300mg (Aliskiren Tablets 5)

Label for Aliskiren Tablets 300 mg, film-coated oral tablets by Par Pharmaceutical. The label indicates each tablet contains Aliskiren Hemifumarate equivalent to 300 mg of Aliskiren. The package contains 30 tablets with storage instructions to keep at controlled room temperature and protect from moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.